Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
6,367
-398
-6% -$634K 3.18% 7
2026
Q1
$8.94M Sell
6,765
-936
-12% -$1.28M 2.67% 7
2025
Q4
$8.25M Buy
7,701
+63
+0.8% +$65.7K 2.46% 7
2025
Q3
$7.39M Buy
7,638
+69
+0.9% +$54.2K 2.29% 9
2025
Q2
$6.07M Buy
7,569
+1,946
+35% +$1.4M 2.09% 10
2025
Q1
$3.73M Buy
5,623
+511
+10% +$372K 1.4% 27
2024
Q4
$3.54M Buy
5,112
+4,645
+995% +$3.34M 1.32% 31
2024
Q3
$389K Buy
+467
New +$417K 0.15% 80

Other funds holding ASML

Hudson Value Partners's ASML Position: Q2 2026 in Review

Hudson Value Partners reduced its ASML (ASML) stake by 5.9% in Q2 2026, selling an estimated $634K and leaving 6,367 shares worth $12.7M. The position accounts for 3.18% of the portfolio, ranked #7.

Hudson Value Partners first reported a position in ASML in Q3 2024 and has held it in 8 quarters since. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Hudson Value Partners held 6,367 shares of ASML worth $12.7M as of Q2 2026.
  • Hudson Value Partners sold 398 ASML shares in Q2 2026, an estimated $634K.
  • ASML made up 3.18% of Hudson Value Partners's portfolio in Q2 2026, its #7 holding.
  • Hudson Value Partners first reported a position in ASML in Q3 2024 and has held it in 8 quarters since.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.